---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-039708"
form_type: "8-K"
ticker: "NXGL"
cik: "0001468929"
company_name: "NEXGEL, INC."
filed_at: "2026-08-21T20:42:03+00:00"
generated_at: "2026-08-21T20:44:06.809116+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# NexGel terminates CEO Adam Levy, appoints Brian Kieser interim CEO, launches strategic review

## Summary
- Adam R. Levy terminated as CEO without cause effective Aug 21, 2026; resigned from board and all officer positions.
- Brian Kieser appointed Interim CEO effective Aug 21, 2026; is CEO of Fountainhead Lifesciences and board member since May 6, 2026.
- Board formed Special Committee for Strategic Review and Value Creation (Kevin Harris, Chair; Steve Glassman) to assess operations.
- Committee authorized to evaluate divestiture, partnerships, restructuring or wind-down of non-core assets; initial framework expected in 30-45 days.
- Levy to provide 90-day transition assistance; Separation Agreement terms not yet finalized, with 8-K amendment to follow.

## SEC filing metadata
- accession: 0001493152-26-039708
- form_type: 8-K
- ticker: NXGL
- cik: 0001468929
- company_name: NEXGEL, INC.
- filed_at: 2026-08-21T20:42:03+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1468929/000149315226039708/0001493152-26-039708-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1468929/000149315226039708/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-039708
- JSON: https://secwatch.observer/filing/0001493152-26-039708.json
- Plain text: https://secwatch.observer/filing/0001493152-26-039708.txt

## Key facts
- Executive change
  Adam R. Levy resigned as Director at NEXGEL, INC..
  - Action: resigned
  - Role: Director
  source text: Mr. Levy resigned from the Company’s Board of Directors
  evidence_url: https://www.sec.gov/Archives/edgar/data/1468929/000149315226039708/0001493152-26-039708-index.htm
- Executive change
  Brian Kieser was appointed as Interim Chief Executive Officer at NEXGEL, INC..
  - Action: appointed
  - Role: Interim Chief Executive Officer
  source text: Effective as of the Separation Date, the Board appointed Brian Kieser to serve as Interim Chief Executive Officer of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1468929/000149315226039708/0001493152-26-039708-index.htm
- Executive change
  Adam R. Levy was terminated as Chief Executive Officer at NEXGEL, INC..
  - Action: terminated
  - Role: Chief Executive Officer
  source text: Effective August 21, 2026 (the “ Separation Date ”), NexGel, Inc. (the “ Company ”) terminated Adam R. Levy’s employment as Chief Executive Officer without Cause (as defined in Mr. Levy’s Executive Employment Agreement, dated July 23, 2026), and Mr. Levy resigned from the Company’s Board of Directors (the “ Board ”) and from all other officer, director, committee and fiduciary positions held by him with the Company and its subsidiaries.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1468929/000149315226039708/0001493152-26-039708-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.